Vedamurthy A, Gangasani N, Ananthakrishnan AN. Vedolizumab or TNF-antagonist use and risk of new or recurrent cancer in patients with inflammatory bowel disease with prior malignancy: A retrospective cohort study. Clin Gastroenterol Hepatol 2020 Oct 13. pii: S1542-3565(20)31396.
PMID: 33065312